ad image

Shareholders

1 / 1
Mallinckrodt Pharmaceuticals
Generics

Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders

Mallinckrodt Pharmaceuticals

PR-M05-19-NI-087May 31, 2019
Allergan, plc
Response

Allergan Responds to Public Shareholder Letter

Allergan, plc

PR-M02-19-NI-047Feb 21, 2019
1 / 1